Today: 29 April 2026
Browse Category

NASDAQ:ERAS 14 January 2026 - 6 March 2026

Tango Therapeutics stock jumps 36% after Q4 results, Erasca cancer trial pact

Tango Therapeutics stock jumps 36% after Q4 results, Erasca cancer trial pact

Tango Therapeutics shares rose 36% after announcing a collaboration with Erasca to test vopimetostat in pancreatic and lung cancers. The company reported a fourth-quarter net loss of $38.7 million and cash reserves of $343.1 million. Tango plans to start a pivotal pancreatic cancer trial in 2026 and released early efficacy data from ongoing studies.
6 March 2026
···

Stock Market Today

  • METAWATER Analysts Boost Earnings Forecasts After Fiscal Year Results
    April 28, 2026, 10:25 PM EDT. METAWATER Co., Ltd. (TSE:9551) reported full-year results showing revenues of JP¥210 billion, 3.4% above forecasts, while earnings per share (EPS) matched analyst expectations. Following these results, five analysts raised their 2027 forecasts to JP¥220.7 billion in revenue and JP¥220 EPS, indicating a 5.2% and 5.0% increase respectively. The consensus price target jumped 17% to JP¥3,100, reflecting improved earnings outlook. Despite recent share declines of 7.5% post-report, analysts remain cautiously optimistic, noting that forecast revenue growth aligns closely with industry averages but slows from historic rates. Analyst price targets range from JP¥2,000 to JP¥3,800, suggesting moderate divergence in sentiment. Overall, the earnings upgrade underscores increased confidence in METAWATER's future profitability.

Latest article

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

29 April 2026
Oracle shares fell 4% and CoreWeave dropped 5.9% Tuesday after a Wall Street Journal report said OpenAI missed recent revenue and user targets. Nvidia, AMD, and Arm Holdings also declined, with the iShares Semiconductor ETF down 3.7%. OpenAI denied internal divisions and said its AI coding product Codex reached 4 million users. Oracle’s credit default swaps hit a two-week high amid concern over its $300 billion cloud deal with OpenAI.
Go toTop